$2.66
-0.0400 (-1.48%)
At Close: Jun 03, 2026
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced positive topline results for ReCePI, a pivotal Phase 3 clinical trial of pathogen reduced INTERCEPT Red Blood Cells (
Cerus Corporation (CERS) Q4 2023 Earnings Call Transcript
06:43pm, Tuesday, 05'th Mar 2024
Cerus Corporation (NASDAQ:CERS ) Q4 2023 Earnings Conference Call March 5, 2024 4:30 PM ET Company Participants Jessica Hanover - Vice President of Corporate Affairs Obi Greenman - President and Chief
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
04:00pm, Tuesday, 05'th Mar 2024
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced financial results for the fourth quarter and full year ended December 31, 2023. Recent highlights include: Fourth-qua
Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024
08:30am, Tuesday, 20'th Feb 2024
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its fourth quarter and full-year 2023 financial results will be released on Tuesday, March 5, 2024, after the cl
Cerus Corporation to Participate in Upcoming Investor Conferences
08:30am, Thursday, 01'st Feb 2024
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced management participation in two upcoming investor conferences. Management plans to attend the BTIG 11th Annual MedTech, Dig
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
11:50am, Friday, 26'th Jan 2024
Cathie Wood bought shares of Tesla, Ark 21Shares Bitcoin ETF, and Cerus on Thursday. Tesla shares plunged 12% on Thursday after a troublesome quarterly report.
3 Growth Stocks That Could Go Parabolic in 2024
09:30am, Monday, 15'th Jan 2024
Small- to mid-cap growth stocks largely struggled over the past two years. With the Federal Reserve likely to pivot on interest rates this year, this group may be poised for a trend reversal.
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update
08:30am, Monday, 08'th Jan 2024
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2023 and provided product revenue guidance for full-
Cerus Corporation to Participate in Upcoming Investor Conferences
08:30am, Friday, 03'rd Nov 2023
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that the Company will participate in two upcoming investor conferences: William “Obi” Greenman, Cerus' president a
Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript
10:52pm, Thursday, 02'nd Nov 2023
Cerus Corporation (NASDAQ:CERS ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Jessica Hanover - Vice President of Corporate Affairs Obi Greenman - President & Chie
Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates
06:47pm, Thursday, 02'nd Nov 2023
Cerus (CERS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.05 per share a year ago.
Cerus Corporation Announces Third Quarter 2023 Financial Results
04:00pm, Thursday, 02'nd Nov 2023
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced financial results for the third quarter ended September 30, 2023. Recent highlights include: Third quarter 2023 total
Bloodbuy Announces Agreement with Cerus Corporation to Offer Pathogen Reduced Cryoprecipitated Fibrinogen Complex on its Digital Marketplace
02:46pm, Wednesday, 01'st Nov 2023
DALLAS--(BUSINESS WIRE)--Bloodbuy, a healthcare software and services company focused on developing cloud-based technologies that transform how biological products are managed and disseminated, today
Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023
08:30am, Thursday, 19'th Oct 2023
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2023 financial results will be released on Thursday, November 2, 2023, after the close of the
Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual Meeting
08:30am, Tuesday, 10'th Oct 2023
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq:CERS) today announced a selection of abstracts and an industry workshop at the 2023 AABB Annual Meeting, taking place in Nashville, TN from
Sign In
Buy CERS